Upregulation of CDH1 reduces the activity of Wnt/β-catenin signaling in non-small cell lung cancer cells, thereby impairing the stem cell characteristics of NSCLC cells [65]. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.